Feasibility and efficacy of preoperative chemoradiation and postoperative liver perfusion chemotherapy for T3 (UICC) pancreatic cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic cancerT3 of UICC TNM classification of malignant tumours 6th edition)
- Registration Number
- JPRN-UMIN000001804
- Lead Sponsor
- Osaka Medical Center for cancer & Cardiovascular Diseases gastrointestinal & hepatobiliary- pancreatic surger
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
unusual running of hepatic artery, renal dysfunction, sever coronary disease, past history of malignant disease or chronic hepatitis, white blood cell count<3000/mm3, platelet count <104/mm3, Activated partial thromboplastin>50sec, ALT,AST>100U/l creatinine>1.5mg/dl
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method